Terms: = Pancreatic cancer AND CNBP, P62633, 7555, ENSG00000169714, ZNF9, RNF163, DM2
10 results:
1. Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment.
Pretta A; Ziranu P; Giampieri R; Donisi C; Cimbro E; Spanu D; Lai E; Pecci F; Balconi F; Lupi A; Pozzari M; Persano M; Murgia S; Pusceddu V; Puzzoni M; Berardi R; Scartozzi M
Dig Liver Dis; 2023 May; 55(5):655-660. PubMed ID: 36513569
[TBL] [Abstract] [Full Text] [Related]
2. Cystic pancreatic neuroendocrine tumors: a multidisciplinary diagnostic challenge.
Bazaga S; Morales-Alvarado J; Bas-Cutrina F; Fernandez Monclús E; Méndez Coca I
Rev Esp Enferm Dig; 2022 Nov; 114(11):691-692. PubMed ID: 35607931
[TBL] [Abstract] [Full Text] [Related]
3.
Deng J; Zhang J; Ye Y; Liu K; Zeng L; Huang J; Pan L; Li M; Bai R; Zhuang L; Huang X; Wu G; Wei L; Zheng Y; Su J; Zhang S; Chen R; Lin D; Zheng J
Cancer Res; 2021 Oct; 81(20):5268-5283. PubMed ID: 34362795
[TBL] [Abstract] [Full Text] [Related]
4. Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus.
Pretta A; Ziranu P; Puzzoni M; Lai E; Orsi G; Liscia N; Molinaro E; Mariani S; Riggi L; Rovesti G; Dubois M; Migliari M; Persano M; Saba G; Impera V; Musio F; Batzella E; Demurtas L; Pusceddu V; Astara G; Faloppi L; Casadei Gardini A; Andrikou K; Cascinu S; Scartozzi M
Tumori; 2021 Dec; 107(6):550-555. PubMed ID: 33243068
[TBL] [Abstract] [Full Text] [Related]
5. Does the use of incretin-based medications increase the risk of cancer in patients with type-2 diabetes mellitus?
Karp I; Sivaswamy A; Booth C
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):489-499. PubMed ID: 30779266
[TBL] [Abstract] [Full Text] [Related]
6. Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study.
Walker EJ; Ko AH; Holly EA; Bracci PM
Int J Cancer; 2015 Mar; 136(6):E646-53. PubMed ID: 25091126
[TBL] [Abstract] [Full Text] [Related]
7. cancer detection rates following enrolment in a disease management programme for type 2 diabetes.
Geier AS; Wellmann J; Wellmann I; Kajüter H; Heidinger O; Hempel G; Hense HW
Diabetologia; 2013 Sep; 56(9):1944-8. PubMed ID: 23722623
[TBL] [Abstract] [Full Text] [Related]
8. Type 2 diabetes mellitus and pancreatic cancer.
McAuliffe JC; Christein JD
Surg Clin North Am; 2013 Jun; 93(3):619-27. PubMed ID: 23632148
[TBL] [Abstract] [Full Text] [Related]
9. Incidence of pancreatic cancer in Greenland 2000-2010.
Kirkegaard J
Int J Circumpolar Health; 2012 May; 71():18368. PubMed ID: 22663941
[TBL] [Abstract] [Full Text] [Related]
10. Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus.
Krechler T; Zeman M; Vecka M; Macasek J; Jachymova M; Zima T; Zak A
Neoplasma; 2011; 58(1):58-64. PubMed ID: 21067267
[TBL] [Abstract] [Full Text] [Related]
